Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
8.23
+0.05 (0.61%)
At close: Jul 6, 2026, 4:00 PM EDT
8.24
+0.01 (0.12%)
After-hours: Jul 6, 2026, 4:10 PM EDT
Precision BioSciences Revenue
Precision BioSciences had revenue of $10.84M in the quarter ending March 31, 2026, with 37,272.41% growth. This brings the company's revenue in the last twelve months to $45.07M, down -11.87% year-over-year. In the year 2025, Precision BioSciences had annual revenue of $34.26M, down -50.12%.
Revenue (ttm)
$45.07M
Revenue Growth
-11.87%
P/S Ratio
4.72
Revenue / Employee
$682,924
Employees
66
Market Cap
212.35M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 34.26M | -34.43M | -50.12% |
| Dec 31, 2024 | 68.70M | 19.97M | 40.98% |
| Dec 31, 2023 | 48.73M | 23.63M | 94.15% |
| Dec 31, 2022 | 25.10M | -90.43M | -78.28% |
| Dec 31, 2021 | 115.53M | 91.24M | 375.72% |
| Dec 31, 2020 | 24.29M | 2.05M | 9.20% |
| Dec 31, 2019 | 22.24M | 11.36M | 104.34% |
| Dec 31, 2018 | 10.88M | 4.40M | 67.84% |
| Dec 31, 2017 | 6.48M | -531.00K | -7.57% |
| Dec 31, 2016 | 7.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 151.12M |
| Compugen | 72.66M |
| Arcturus Therapeutics Holdings | 54.71M |
| Q32 Bio | 53.74M |
| Coherus Oncology | 46.88M |
| Keros Therapeutics | 33.18M |
| Armata Pharmaceuticals | 5.20M |
| Korro Bio | 3.84M |
DTIL News
- 7 days ago - Precision BioSciences announces addition to the Russell 2000 Index - TheFly
- 7 days ago - Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors - Business Wire
- 27 days ago - Precision BioSciences initiated with an Outperform at Oppenheimer - TheFly
- 4 weeks ago - Precision BioSciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Precision BioSciences Transcript: Study update - Transcripts
- 5 weeks ago - Precision BioSciences Press release: Study update - Filings
- 5 weeks ago - Precision BioSciences Slides: Study update - Filings
- 5 weeks ago - Precision BioSciences presents new data from ELIMINATE-B study at EASL - TheFly